Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Scopolamine versus propofol for prevention of nausea and vomiting after cesarean section under spinal anesthesia
IRCT20201207049639N6Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Nov 2021
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of scopolamine and propofol in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoint: Nausea and vomiting after surgery. Started Nov 2021; status: completed.
02
Drugs
scopolaminepropofol
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20201207049639N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201207049639N6.